Share of the population living with HIV receiving antiretroviral therapy in Algeria

Algeria: Share of the population living with HIV receiving antiretroviral therapy was 68.3% in 2024. ◆ Volatile

Latest (2024)
68.3%
Change on year
down 3.6%
World rank
85th
of 149 countries
All-time high
73.9%
in 2021
All-time low
0.0%
in 1990
Years of data
35
1990–2024

Share of the population living with HIV receiving antiretroviral therapy in Algeria, 1990–2024

0204060801990200720241990: 0 %1991: 0 %1992: 0 %1993: 0 %1994: 0 %1995: 0 %1996: 0 %1997: 0 %1998: 6.2 %1999: 7.2 %2000: 6.1 %2001: 7.2 %2002: 7.6 %2003: 8 %2004: 9 %2005: 10.1 %2006: 13.1 %2007: 13 %2008: 12.8 %2009: 15.8 %2010: 20.9 %2011: 23.3 %2012: 27.6 %2013: 35.4 %2014: 43 %2015: 51.5 %2016: 59.4 %2017: 64 %2018: 68.7 %2019: 71.9 %2020: 72 %2021: 73.9 %2022: 69.2 %2023: 70.9 %2024: 68.3 %

Source: Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Measured in %.

Analysis

The most recent figure for share of the population living with hiv receiving antiretroviral therapy in Algeria is 68.3%, measured in 2024.

The figure is down 3.6% on the previous year and up 59.0% over ten years.

Over the whole period, share of the population living with hiv receiving antiretroviral therapy in Algeria peaked at 73.9% in 2021 and was at its lowest, 0.0%, in 1990.

That places Algeria 85th out of 149 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Share of the population living with HIV receiving antiretroviral therapy in Algeria, year by year

Annual values for Share of the population living with HIV receiving antiretroviral therapy in Algeria, 1990 to 2024.
Year % Change
1990 0.0% —
1991 0.0% —
1992 0.0% —
1993 0.0% —
1994 0.0% —
1995 0.0% —
1996 0.0% —
1997 0.0% —
1998 6.2% —
1999 7.2% +15.7%
2000 6.1% -15.4%
2001 7.2% +18.8%
2002 7.6% +5.2%
2003 8.0% +4.9%
2004 9.0% +12.8%
2005 10.1% +12.1%
2006 13.1% +30.4%
2007 13.0% -1.1%
2008 12.8% -1.5%
2009 15.8% +23.1%
2010 20.9% +32.7%
2011 23.3% +11.6%
2012 27.6% +18.3%
2013 35.4% +28.1%
2014 43.0% +21.4%
2015 51.5% +19.8%
2016 59.4% +15.4%
2017 64.0% +7.6%
2018 68.7% +7.4%
2019 71.9% +4.7%
2020 72.0% +0.1%
2021 73.9% +2.6%
2022 69.2% -6.4%
2023 70.9% +2.5%
2024 68.3% -3.6%

Algeria compared with similar countries

  • Algeria's 68.3% is above the median for upper middle income countries, which is 65.5%, 1.0× the median. (43 countries reporting)
  • Algeria's 68.3% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 58.4%, 1.2× the median. (21 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
1990s 1.3% 0.0% 7.2% 10
2000s 10.3% 6.1% 15.8% 10
2010s 46.6% 20.9% 71.9% 10
2020s 70.9% 68.3% 73.9% 5

Countries ranked near Algeria

  1. 82 Estonia 68.6% compare
  2. 83 Kuwait 68.6% compare
  3. 84 Mali 68.3% compare
  4. 86 Cuba 67.8% compare
  5. 87 Oman 67.7% compare
  6. 88 Panama 67.0% compare

See the full ranking of 149 places →

More reference data data for Algeria

All data for Algeria →

Frequently asked questions

What is share of the population living with hiv receiving antiretroviral therapy in Algeria?
Share of the population living with hiv receiving antiretroviral therapy in Algeria was 68.3% in 2024, according to Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data.
What is the highest share of the population living with hiv receiving antiretroviral therapy recorded in Algeria?
The highest recorded value was 73.9% in 2021.
What is the lowest share of the population living with hiv receiving antiretroviral therapy recorded in Algeria?
The lowest recorded value was 0.0% in 1990.
How does Algeria rank for share of the population living with hiv receiving antiretroviral therapy?
Algeria ranks 85th out of 149 countries with data for 2024.
Is share of the population living with hiv receiving antiretroviral therapy rising or falling in Algeria?
Over the last ten years it is up 59.0%. The long-run trend across the full record is volatile.
Where does this Algeria data come from?
The figures come from Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as part of Share of the population living with HIV receiving antiretroviral therapy. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Share of the population living with HIV receiving antiretroviral therapy in Algeria. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Retrieved 29 September 2026, from https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/algeria/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/algeria/">Share of the population living with HIV receiving antiretroviral therapy in Algeria</a> — Statizoid

About this data

Indicator
Share of the population living with HIV receiving antiretroviral therapy
Unit
%
Source
Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
149 places, 5,062 data points, 1990–2024
Last refreshed

Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.